214973-83-8

Basic information

• Product Name: Carbamic acid, [1-(4-bromophenyl)-1-methylethyl]-, 1,1-dimethylethyl ester
• CAS NO: 214973-83-8
• Molecular Formula: C14H20BrNO2
• Molecular Weight: 314.222
• Mol File: 214973-83-8.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 390.6±25.0 °C(Predicted)
• Density: 1.253±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Carbamic acid, [1-(4-bromophenyl)-1-methylethyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [1-(4-bromophenyl)-1-methylethyl]-, 1,1-dimethylethyl ester(214973-83-8)
• EPA Substance Registry System: Carbamic acid, [1-(4-bromophenyl)-1-methylethyl]-, 1,1-dimethylethyl ester(214973-83-8)

Safety Data

• Hazardous Substances Data: 214973-83-8(Hazardous Substances Data)

Usage

General Description

Carbamic acid, [1-(4-bromophenyl)-1-methylethyl]-, 1,1-dimethylethyl ester is a chemical compound commonly known as terbuthylazine. It is a pre-emergent herbicide and is used to control the growth of weeds in agricultural and horticultural crops. Terbuthylazine works by inhibiting photosynthesis in plants, effectively preventing the growth of weeds. It is often applied as a pre-emergent treatment, meaning it is used before the weeds germinate to prevent their growth. Terbuthylazine is considered to have low acute toxicity to mammals but should be handled with care and in accordance with safety guidelines when being used.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 17797-12-5 1-(4-bromophenyl)-1-methylethylamine 
• 32454-35-6 2-(4-bromophenyl)-2-methylpropionic acid 
• 1173047-86-3 2-(4-bromophenyl)propan-2-amine hydrochloride 
• 101184-73-0 2-(4-bromophenyl)-2-methylpropanenitrile 
• 850144-81-9 4-(1-aminocarbonyl-1-methylethyl)-1-bromobenzene 
• 75-65-0 tert-butyl alcohol 
• 64586-21-6 1-(2-azidopropan-2-yl)-4-bromobenzene 
• 2712-78-9 bis-[(trifluoroacetoxy)iodo]benzene 

Downstream Products

• 335592-60-4 tert-butyl (2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-propan-2-yl)carbamate 
• 1588517-19-4 tert-butyl (2-(4-cyanophenyl)propan-2-yl)carbamate 
• 1374263-32-7 tert-butyl {1-methyl-1-[4-(2-phenyl-9H-imidazo[1,2-d]pyrido[2,3-b][1,4]benzodiazepin-3-yl]phenyl]ethyl}carbamate 
• 494773-23-8 4-(2-(4-bromophenyl)propan-2-yl)morpholine 
• 335592-59-1 4-[4-(1-tert-butoxycarbonylamino-1-methylethyl)phenyl]-2,5-dichloropyrimidine 
• 335592-43-3 4-[4-(1-tertbutoxycarbonylamino-1-methylethyl)phenyl]-5-chloro-N-[4-(2-hydroxyethyl)phenyl]pyrimidine-2-amine 
• 937366-50-2 C₂₄H₂₆BrClN₄O₂ 

Relevant articles and documents

SUBSTITUTED PYRAZOLE COMPOUNDS AS TOLL RECEPTOR INHIBITORS

Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, and R5 are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

A compound of formula (I): wherein the substituents are as defined in the description. Medicinal products containing the same which are useful in treating or preventing pathologies which are the result of activation of the RhoA/ROCK pathway and phosphorylation of the myosin light chain.

PHARMACEUTICALLY ACTIVE COMPOUNDS

The invention is directed to compounds of general formula (I), and pharmaceutical compositions containing such compounds. The compounds and compositions have valuable pharmaceutical properties. In particular, they may be used for the treatment of cancer. Novel intermediates and novel methods of preparation are also disclosed.